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Abstract
Whole grain intake is associated with lower CVD risk in epidemiological studies. It is unclear to what extent cereal ﬁbre, located primarily
within the bran, is responsible. This review aimed to evaluate association between intake of whole grain, cereal ﬁbre and bran and CVD risk.
Academic databases were searched for human studies published before March 2018. Observational studies reporting whole grain and cereal
ﬁbre or bran intake in association with any CVD-related outcome were included. Studies were separated into those deﬁning whole grain using
a recognised deﬁnition (containing the bran, germ and endosperm in their natural proportions) (three studies, seven publications) and those
using an alternative deﬁnition, such as including added bran as a whole grain source (eight additional studies, thirteen publications). Intake of
whole grain, cereal ﬁbre and bran were similarly associated with lower risk of CVD-related outcomes. Within the initial analysis, where studies
used the recognised whole grain deﬁnition, results were less likely to show attenuation after adjustment for cereal ﬁbre content. The ﬁbre
component of grain foods appears to play an important role in protective effects of whole grains. Adjusting for ﬁbre content, associations
remained, suggesting that additional components within the whole grain, and the bran component, may contribute to cardio-protective
association. The limited studies and considerable discrepancy in deﬁning and calculating whole grain intake limit conclusions. Future research
should utilise a consistent deﬁnition and methodical approach of calculating whole grain intake to contribute to a greater body of consistent
evidence surrounding whole grains.
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CVD is a major cause of death worldwide, accounting for 31 % of
deaths globally in 2015(1). As well as non-preventable risk factors
such as age and ethnicity, factors such as dyslipidaemia, hypertension, abdominal obesity and pre-existing type 2 diabetes
mellitus (T2DM) can contribute to the risk of CVD(2,3). Diet can
play a role in managing and reducing the risk of these associated
factors, and a diet high in whole grains is consistently found to be
protective against CVD(4,5). ‘Whole grains’ refer to grains that
contain the relative proportions of bran, germ and endosperm as
they would occur naturally in the intact grain; as opposed to
reﬁned grains that have the bran and germ removed during
processing. The precise mechanisms behind the cardio-protective
effects of whole grains are not yet completely understood; however, many of those proposed involve the role of the cereal ﬁbre
located primarily within the bran component. For example, whole
grains high in soluble ﬁbre, such as oats and barley, may reduce
the risk of CVD by decreasing serum LDL-cholesterol and
improving blood glucose and insulin responses(6).

While it is certain that the cereal ﬁbre plays a role in the
cardio-protective association of whole grain foods, there is still
debate as to what extent it is responsible. There are other
constituents of the whole grain that may contribute to lower risk
of CVD, including Mg(7), vitamin E and bioactive compounds
such as phyto-oestrogens(8). It is commonly considered that the
contribution of these additional constituents, or perhaps, a
synergistic effect of consuming the grain’s nutrients and
bioactive compounds together, is greater than any beneﬁts of
cereal ﬁbre alone, if it were consumed outside of the
whole grain.
As the bran component of the grain, removed within the
reﬁning process, contains the overwhelming majority of cereal
ﬁbre as well as these other constituents within the aleurone
layer, comparing whole grain with reﬁned grain intake is not
appropriate to address this question. Instead, research needs to
compare or adjust whole grain intake with cereal ﬁbre intake
and bran speciﬁcally.

Abbreviations: CRP, C-reactive protein; HPFS, Health Professionals Follow-up Study; HR, hazard ratio; NHS, Nurses’ Health Study; RR, relative risk; T2DM, type
2 diabetes mellitus.
* Corresponding author: E. M. Barrett, fax +61 2 4221 4844, email emb952@uow.edu.au
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However, a major issue in attempts to investigate comparative association of cereal ﬁbre, whole grain and bran to date, is
the lack of consistency in deﬁnition and calculation of whole
grains. Many of the large meta-analyses providing evidence for
the health association of whole grains draw conclusions based
on studies that deﬁne whole grains in various ways, including
those that consider added bran and germ as whole grain
sources(9,10). In addition, many studies determined whole grain
intake based on categorisation of mixed foods as either a whole
grain or a reﬁned grain food rather than calculating whole grain
content as a dry weight of the ingredients within all foods. This
method has the potential to overestimate the contribution to
whole grain intake from some foods categorically considered
whole grain, for example, dark breads that may use some
reﬁned ﬂours. Alternative whole grain food deﬁnitions such as
breakfast cereals that contain at least 25 % whole grain or
bran(11), or the recently developed 30 % cut-off recommended
by the HEALTHGRAIN forum(12), have value in food labelling
but are problematic in deﬁning precise levels of intake in
research. These methods can fail to capture the whole grain
consumed in small amounts from food which do not meet these
deﬁnitions but which could potentially accumulate to a signiﬁcant contribution to total intake.
Therefore, to investigate the true cardio-protective association of whole grains, we considered the extent and quality of
evidence for whole grains analysed only when using a recognised deﬁnition (namely, containing the bran, germ and endosperm in their natural proportions) and calculated on a g/100 g
dry-weight basis. To provide insight into the comparative
association of the cereal ﬁbre component outside of the whole
grain, we summarised evidence from studies that compared
CVD-related health associations of intake of whole grain with
intake of cereal ﬁbre and/or bran.
Therefore, the aim of this review was to shed light on the
relative contribution of the cereal ﬁbre and bran components to
the cardiovascular protective association found with whole
grain intake.

Methods
The systematic literature review was completed in accordance
with the Preferred Reporting Items for Systematic Reviews and
Meta-Analyses guidelines(13). The details of the review were
recorded and registered with PROSPERO (International Prospective Register of Systematic Reviews, http://www.crd.york.
ac.uk/PROSPERO), registration number CRD42017069226
before commencement.

Inclusion and exclusion criteria
Articles were required to have considered both whole grain
intake and cereal ﬁbre and/or bran intake in association with
CVD-related health outcomes in humans. Since there were only
limited articles identiﬁed as meeting this criterion, no restrictions were placed on the CVD-related health outcomes examined and included. These could include but were not limited to
disease biomarkers, anthropometric measures, morbidity and

mortality. Results were restricted to those published in English
and contained within peer-reviewed journals, and there were
no restrictions based on the time of publication. Editorials,
reviews, meta-analyses and conference abstracts were
excluded.

Exposure – initial analysis. Articles must have reported on
total whole grain intake, and those examining intake of only a
deﬁned set of whole grain foods or dietary patterns including
whole grains were excluded. The deﬁnition of whole grains
used was in accordance with that of American Association of
Cereal Chemists International (AACCI): ‘the intact, ground,
cracked or ﬂaked caryopsis, whose principal anatomical components – the starchy endosperm, germ and bran – are present
in the same relative proportions as they exist in the intact caryopsis’(14). This deﬁnition is similar to those used in Europe and
Australasia but critically deﬁnes whole grains, not whole grain
foods. Also, it means that articles that included added bran or
germ as a source of whole grain were excluded from the initial
analysis.
Exposure – expanded analysis. Initial scoping found a limited
amount of studies meeting the described inclusion criteria.
Consequently, a second review of the evidence was conducted,
expanding the criteria to include studies with a broader deﬁnition of whole grains. This expanded analysis includes studies
that may not have deﬁned whole grains as per the AACCI
deﬁnition but may have utilised whole grain food deﬁnitions.
For example, several articles that utilised a categorisation system of whole grain and reﬁned grain foods, which categorised
added bran and germ as a whole grain food, were included in
an expanded analysis. Similarly, articles that met all other
selection criteria but did not clearly explain how whole grain
intake was deﬁned or categorised were included in this
expanded analysis.
Comparison. To be considered for inclusion, studies must have
made a comparison of whole grain intake with cereal ﬁbre and/
or bran intake. This may have been completed through
assessment of cereal ﬁbre/bran intake separately, adjustment of
whole grain intake for cereal ﬁbre/bran or by matching whole
grain and reﬁned grain intake based on cereal ﬁbre/bran content. Bran was included as an alternative comparison as it is the
portion of the grain containing the majority of the cereal ﬁbre.

Study design. Due to wide disparity and potential differences
between acute exposure and long-term exposure, this paper
reports only the results of observational studies. Intervention
studies will be reported in a separate review. A summary of the
participants, exposure, comparisons, outcomes and study
design is presented in Table 1.
Search term and strategy
Relevant human journal articles were identiﬁed in medical
databases Scopus, Web of Science, CINAHL plus, CENTRAL in
Cochrane Library and PubMed published before March 2018
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Table 1. PICOS criteria for inclusion and exclusion of studies in initial
analysis*
Parameter

Description

Population

Males and female humans of any age, health status,
socio-economic status and geographical location
Whole grain intake, whole grain defined according to
the AACCI definition†
Cereal fibre intake or bran intake
Association of exposure/comparison on any
CVD-related health outcome
Observational studies

Exposure
Comparison
Outcomes
Study design

PICOS, population, intervention, comparator, outcome, study design; AACCI,
American Association of Cereal Chemists International.
* PICOS criteria, population, intervention (exposure), comparator, outcomes, study
design.
† Expanded to include studies not meeting this definition in expanded analysis.

using the following key words: ‘cardiovascular’, ‘coronary’,
‘stroke’, ‘cholesterol’, ‘triglycerides’, ‘lipids’, ‘obes*’, ‘overweight’, ‘glucose’ and ‘diabetes’ in combination with ‘wholegrain*’ or ‘grain*’, as well as ‘cereal*’ or ‘bran’ and ‘ﬁbre’ or
‘ﬁber’. The full search strategy (SCOPUS) has been presented in
online Supplementary material.
The titles of the articles were screened for inclusion by one
author. The abstracts of remaining articles were then reviewed.
After exclusion based on abstract, the full text of each potentially eligible article was retrieved. Two authors (E. M. B. and
E. J. B.) separately assessed the full text studies for inclusion in
the review. The reference lists of included articles were hand
searched for additional studies that met the criteria.

Data extraction
One author (E. M. B.) extracted the required information and
summarised the data in table format, which was reviewed by a
second author (E. J. B.). Studies meeting the accepted deﬁnition of whole grains (initial analysis) were summarised
separately for expanded analysis. Within both groups, whole
grain, cereal ﬁbre and bran intake data were extracted in
separate tables. Each summary table included ﬁrst author’s last
name, publication year, study name, participants, country in
which the study was performed, CVD-related outcomes
examined, highest and lowest median intake, covariate
adjustments, main results and statistical signiﬁcance. When
bran intake data were extracted, the table also included
whether the bran was total bran (naturally occurring plus
added) or added bran.

Quality assessment
The design of each included study was identiﬁed and recorded.
The National Health and Medical Research Council (NHMRC)
levels of evidence guidelines(15) were used to assign a level of
evidence to each study based on design. In addition, the
National Institutes of Health (NIH) Quality Assessment Tool for
Observational Cohort and Cross-Sectional Studies(16) was used
to guide critical appraisal of articles. The NIH quality assessment tool provides a checklist of fourteen criteria that can be
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applied to cohort and cross-sectional studies to evaluate internal validity. Studies were assessed on the basis of research
objective, study population speciﬁcation, participation rate,
inclusion/exclusion criteria, sample size justiﬁcation, time
frame, exposure and outcome measurement, blinding, attrition
and confounders. The NIH tool then includes a subjective
quality rating (good, fair or poor) that the reviewer decides on
based on their overall evaluation, rather than a direct numerical
ranking.

Method of analysis
Due to the wide range of CVD-related outcomes assessed
within limited studies, a meta-analysis was not possible. Instead,
studies were grouped based on comparison measure (cereal
ﬁbre or bran intake) and where possible, on health outcome
assessed, and data were examined and synthesised qualitatively. The separation of articles within the initial and expanded
analysis allows an examination of how the quality of evidence
differs when restricted to articles using the currently accepted
deﬁnition of whole grains. The quality assessment process was
also used to inform the synthesis of results, with studies of
higher quality guiding the interpretation of ﬁndings and subsequent discussion.

Results
Our search strategy identiﬁed 1909 articles (Fig. 1). Duplicates
were removed and titles were screened for relevance, with 671
articles selected for screening of abstract. After screening for
both title and abstracts, ninety-six full-text citations remained,
with a further seventy-three articles excluded because they did
not analyse both whole grain and cereal ﬁbre or bran intake.
One article was excluded as it measured only non-CVD-related
outcomes, and two articles were excluded because they deﬁned
cereal ﬁbre as the ﬁbre sourced from breakfast cereals only.
A further twelve articles were excluded from the initial analysis
because they did not use the AACCI deﬁnition of whole grain
and one article excluded based on no clear description of how
whole grain foods were deﬁned (later included within the
expanded analysis). Seven articles (based on three studies)
remained in the initial analysis.
When the expanded criterion was applied to include the
articles that did not use the AACCI deﬁnition of whole grain,
thirteen previously excluded articles (eight additional studies)
were included (Fig. 1). They were previously excluded as eleven of these articles included added bran and/or germ as a
source of whole grain, one article did not include whole grain
bread as a source of whole grain intake, and one article did not
provide sufﬁcient detail as to how whole grain intake was
deﬁned.
A summary of articles exploring the associations between
whole grain, cereal ﬁbre and bran intake within the initial
analysis are presented in Tables 2, 3 and 4, respectively. Similarly, Tables 5, 6 and 7 present a summary of articles in the same
format for when the criteria were expanded.

Downloaded from https://www.cambridge.org/core. University of Wollongong, on 25 Mar 2019 at 22:55:33, subject to the Cambridge Core terms of use, available at https://www.cambridge.org/core/terms. https://doi.org/10.1017/S000711451900031X

Whole grains and CVD

E. M. Barrett et al.

mortality in healthy participants (two articles), incidence of
CHD (one article), the metabolic syndrome (one article) and
stroke (one article): and markers of CVD risk, anthropometric
measures (three articles), blood lipid proﬁle (two articles),
blood glucose measures (three articles), inﬂammatory markers
(one article) and change in coronary artery diameter and percentage stenosis (one article) (Tables 5–7).

1909 articles found with
original search strategy
PubMed n 528
Scopus n 487
Web of Science n 598
CINAHL Plus n 157
CENTRAL in Cochrane Library
n 139
1238 articles removed
by title screening and
removing duplicates

Quality assessment
671 original research articles
for abstract screening
PubMed n 127
Scopus n 196
Web of Science n 177
CINAHL Plus n 116
Cochrane CENTRAL n 55
575 non-relevant
articles removed after
abstract screening
96 full-text articles were
reviewed against inclusion
criteria
89 full-text articles were excluded
• Did not report on both cereal fibre or
bran and whole grain intake (n 73)
• Irrelevant study outcomes (n 1)
• Calculated cereal fibre as fibre from
breakfast cereal only (n 2)
• Incorrect definition of whole grain
used (n 12)
• Whole grain categorisation not
defined (n 1)

7 articles (3 studies) remained
for inclusion in initial analysis

13 articles (8 additional studies)
included in expanded analysis

Fig. 1. Flow diagram of study selection process.

Data extraction
Within the initial analysis, seven articles, which were based on
three primary studies, investigated various associations between
whole grain, bran and cereal ﬁbre intake and cardiovascularrelated outcomes. The primary studies were the Nurses’ Health
Study (NHS) I and II and the Health Professionals Follow-up
Study (HPFS).
The following CVD-related outcomes were assessed in relation to whole grain and cereal ﬁbre and/or bran intake within
the initial analysis, each within single article: incidence of
T2DM, CVD mortality and all-cause mortality in healthy participants and those with diabetes, hypertension, CHD, long-term
weight gain and various inﬂammatory markers (Tables 2–4).
Within the expanded analysis (thirteen articles reporting on
eight new studies), two articles directly compared outcomes
between whole grain intake and bran intake and eight articles
directly compared outcomes between whole grain intake and
cereal ﬁbre intake. One article adjusted whole grain intake for
cereal ﬁbre intake, and one article compared association
between whole grain and non-whole grain intake matched on
cereal ﬁbre content. The expanded analysis investigated the
incidence of T2DM (three articles), CVD mortality and all-cause

The level of evidence among the articles according to the
NHMRC guidelines ranged from level II (twelve prospective
cohort studies observing mortality or morbidity end points) to
level IV (six cross sectional analysis studies) (Table 8). Five of
the seven articles within the initial analysis were assigned a
level II, while seven of the thirteen articles within the expanded
analysis were assigned a level II.
While the majority of articles (10/19) were of good quality as
determined using the NIH quality assessment tool, the ratio of
good to fair quality was better in the initial analysis (6:1 v. 4:9 in
the expanded analysis) (Table 8). The study design used often
limited the quality that could be attained, with cross-sectional
design unable to measure exposure before outcome and unable
to assess associations over a sufﬁcient time frame. In addition,
articles that only assessed exposure once over the study period
and articles that relied on self-reported outcome measures were
often assessed as lower quality than those that assessed exposure multiple times and used validated measures.

Initial analysis
Of the seven articles that assessed whole grain intake in the
initial analysis, six found a signiﬁcant inverse association with
CVD-related outcomes(5,17–21), however, two of these found the
association attenuated when adjusting for cereal ﬁbre and
whole grain constituents(5,20). All six articles investigating bran
intake found a signiﬁcant inverse association with CVD-related
outcomes(4,5,17–21), although one of these articles investigated
two separate cohorts and found a non-signiﬁcant inverse
association in one cohort(19). There were mixed results on the
association with cereal ﬁbre, with two articles showing a signiﬁcant inverse association(17,21) between intake and risk factors, and a third article showing no association(4).

Whole grain intake compared with bran intake. The highest
intake of whole grain was associated with 12 % lower risk of
CVD mortality (hazard ratio (HR) 0·88, 95 % CI 0·82, 0·96,
P = 0·001) and an 8 % lower risk of all-cause mortality (HR 0·92,
95 % CI 0·89, 0·96, P < 0·001) compared with the lowest intake
in a large combined cohort of the NHS I and the HPFS(18).
Within the same cohort, the association of high bran intake with
lower risk of CVD mortality was slightly greater. A 20 % lower
risk for the highest intake of total bran (HR 0·80, 95 % CI 0·73,
0·87, P < 0·001) and a 24 % lower risk for the highest intake of
added bran (HR 0·76, 95 % CI 0·70, 0·83, P < 0·001) compared
with lowest intake were observed. Similarly, high whole grain
and total bran intake were both associated with lower risk of
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Table 2. Characteristics of studies within initial analysis exploring association of whole grain intake with outcomes related to CVD
Study first author, year
(reference)
He, 2010

(4)

Study

Cohort

Participants

Country Outcome

Highest
intake

Lowest
intake

PCS

NHS I

7822 F with
T2DM

USA

32·6 g/d

4·8 g/d

CVD death

All-cause death
Jensen, 2004

PCS

HPFS

CrossNHS I
sectional

42 850 M

USA

CHD

42·4 g/d

3·5 g/d

902 F with
T2DM

USA

CRP (mg/l)

35·4 g/d

4·75 g/d

47·8 g/d

4·2 g/d

ICAM-1 (ng/ml)
E-selectin (ng/ml)
TNF-R2 (pg/ml)
Wu, 2015(18)

PCS

NHS I and
HPFS

74 341 F,
43 744 M

USA

CVD death

All-cause death

Results

P

Age, smoking status, BMI, alcohol
intake, physical activity, parental
history of MI, menopausal status
and use of hormone therapy,
duration of diabetes mellitus.
Intake of total energy, PUFA,
saturated fat, trans fat, Mg and
folate

RR 0·70 (95 % CI P = 0·07
0·46, 1·06)

RR 0·89 (95 % CI P = 0·11
0·69, 1·14)
Age, BMI, added bran intake, added HR 0·84 (95 % CI P = 0·02
0·71, 0·98)
germ intake, energy intake,
smoking status, alcohol intake,
physical activity, family history of
MI, use of vitamin E supplement,
intake of PUFA, saturated fat,
trans fat, fruit, vegetables and fish
Whole grain constituent intake:
HR 0·85 (95 % CI P = 0·06
dietary fibre, folate, glycaemic
0·71, 1·02)
load, dietary vitamin B6, vitamin E,
Mg and Mn
Q1 6·60 v. Q5
P = 0·03
Age, BMI, smoking status, alcohol
5·52
intake, physical activity, aspirin
use, HbA1c, history of
hypertension or
hypercholesterolaemia,
postmenopausal hormone use,
glycaemic index and Mg
Q1 316 v. Q5 306 P = 0·19
Q1 65·6 v. Q5
P = 0·96
65·4
Q1 2647 v. Q5
P = 0·017
2435
Age, ethnicity, BMI, smoking status, HR 0·88 (95 % CI P = 0·001
0·82, 0·96)*
pack years smoked, years since
quitting for past smoker, alcohol
intake, physical activity, family
history of diabetes, cancer and
heart disease, multivitamin use,
aspirin use at least once per
week, history of hypertension,
high cholesterol or diabetes at
baseline, total energy intake,
postmenopausal status and
postmenopausal hormone use,
modified alternative healthy eating
index (excludes whole grains)
HR 0·92 (95 % CI P < 0·001
0·89, 0·96)*

Whole grains and CVD

Qi, 2006(17)

(5)

Covariates

5
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Table 2. Continued
Study first author, year
(reference)
(19)

De Munter, 2007

Study

Cohort

Participants

Country Outcome

Highest
intake

Lowest
intake

PCS

NHS I

167 737 F

USA

31·2 g/d

3·7 g/d

39·9 g/d

6·2 g/d

46·0 g/d

3·3 g/d

T2DM

NHS II
Flint, 2009(20)

PCS

HPFS

HPFS

31 684 M

27 082 M

USA

USA

Hypertension

Weight change over 8
years (kg)

23·8 g/d
change

–14·2 g/d
change

Results

RR 0·75 (95 % CI
Age, smoking status, physical
0·68, 0·83)
activity, alcohol intake, use of
hormone replacement therapy,
oral contraceptive use, family
history of T2DM, intake of coffee,
sugar-sweetened soft drinks and
fruit punch (non-alcoholic), total
energy intake, processed meat
intake, PUFA to saturated fat
intake ratio, BMI
RR 0·86 (95 % CI
0·72, 1·02)
Age, energy intake, family history of RR 0·81 (95 % CI
0·75, 0·87)
CHD and hypertension, smoking
status, alcohol intake, marital
status, profession, height, fruit
and vegetable intake, Na intake,
physical activity, multivitamin use,
cholesterol screening
Cereal fibre intake
RR 0·94 (95 % CI
0·84, 1·05)
Q1 1·24 (SD 0·23) v.
Age, baseline exposure, smoking
status, baseline weight, baseline
Q5 0·75 (SD 0·22)
values and changes in refined
grains, total energy intake,
physical activity, alcohol intake,
protein intake and trans,
saturated, MUFA and PUFA
intake

P
P < 0·001

P = 0·03
P < 0·0001

P = 0·23
P < 0·0001

E. M. Barrett et al.

Koh-Banerjee, 2004(21)

PCS

Covariates

PCS, prospective cohort study; NHS, Nurses’ Health Study; F, female; T2DM, type 2 diabetes mellitus; MI, myocardial infarction; RR, relative risk; HPFS, Health Professionals Follow-up Study; M, male; HR, hazard ratio; CRP, C-reactive
protein; ICAM-1, intercellular adhesion molecule 1; TNF-R2, TNF receptor 2.
* Pooled HR for whole grain intake without added bran/germ. Located within Wu et al.(18) online Supplementary Table S4.
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Table 3. Characteristics of studies within initial analysis exploring associations of cereal fibre intake with outcomes related to CVD
Study first author,
year (reference)
He, 2010

(4)

Study

Cohort Participants

PCS

NHS I

Country Outcome

7822 F with T2DM USA

CVD death

Lowest intake

Covariates

Results

6·29 g/d

1·9 g/d

Age, smoking status, BMI, alcohol
intake, physical activity, parental
history of MI, menopausal status
and use of hormone therapy,
duration of diabetes mellitus.
Intake of total energy, PUFA,
saturated fat, trans fat, Mg and
folate

RR 0·89 (95 % CI
0·57, 1·41)

P = 0·41

RR 0·86 (95 % CI
0·66, 1·12)
N/A

P = 0·10

All-cause death
(17)

Qi, 2006

Cross-sectional NHS I

902 F with T2DM

USA

Koh-Banerjee,
2004(21)

PCS

27 082 M

USA

HPFS

CRP (mg/l)

TNF-R2 (pg/ml)
Weight change
over 8 years
(kg)

N/A

N/A

Age, BMI, smoking status, alcohol
intake, physical activity, aspirin
use, HbA1c, history of
hypertension or
hypercholesterolaemia,
postmenopausal hormone use,
glycaemic index and Mg

5·1 g/d change –2·2 g/d change Age, baseline exposure, smoking
status, baseline weight, baseline
values and changes in refined
grains, total energy intake,
physical activity, alcohol intake,
protein intake and trans,
saturated, MUFA and PUFA
intake

P

P = 0·03

Whole grains and CVD

Highest intake

P = 0·01
Q1 1·10 (SD 0·20) v. P = 0·0002
Q5 0·76 (SD 0·20)

PCS, prospective cohort study; NHS, Nurses’ Health Study; F, female; T2DM, type 2 diabetes mellitus; MI, myocardial infarction; RR, relative risk; CRP, C-reactive protein; N/A, not available; TNF-R2, TNF receptor 2; HPFS, Health
Professionals Follow-up Study; M, male.

7
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Table 4. Characteristics of studies within initial analysis exploring associations of bran intake with outcomes related to CVD
Study first author, year
(reference)
(4)

He, 2010

Study

Cohort

Participants

Country Outcome

Bran

Highest
intake

Lowest
intake

PCS

NHS I

7822 F with
T2DM

USA

Total*

9·7 g/d

0·8 g/d

CVD death

All-cause death

(5)

Jensen, 2004

HPFS

CrossNHS I
sectional

42 850 M

902 F with
T2DM

USA

USA

CHD

CRP (mg/l)

ICAM-1 (ng/ml)
E-selectin (ng/ml)
TNF-R2 (ng/ml)

0·0 g/d

Total

9·7 g/d

0·8 g/d

Added

N/A

0·0 g/d

Added

6·85 g/d

0·0 g/d

Total

10·9 g/d

1·6 g/d

Results

Age, smoking status, BMI, alcohol
intake, physical activity, parental
history of MI, menopausal status
and use of hormone therapy,
duration of diabetes mellitus.
Intake of total energy, PUFA,
saturated fat, trans fat, Mg and
folate

RR 0·65 (95 % CI P = 0·04
0·43, 0·99)

RR 0·36 (95 %
0·24, 0·54)
RR 0·72 (95 %
0·56, 0·92)
RR 0·45 (95 %
0·36, 0·57)
HR 0·72 (95 %
0·61, 0·84)

P

CI P < 0·001
CI P = 0·01
CI P < 0·001

CI
Age, BMI, added germ intake,
energy intake, smoking status,
alcohol intake, physical activity,
family history of MI, use of vitamin
E supplement, intake of PUFA,
saturated fat, trans fat, fruit,
vegetables and fish
Whole grain constituent intake:
HR 0·71 (95 % CI
dietary fibre, folate, glycaemic
0·59, 0·85)
load, dietary vitamin B6, vitamin E,
Mg and Mn
Q1 6·29 v. Q5
Age, BMI, smoking status, alcohol
4·96
intake, physical activity, aspirin
use, HbA1c, history of
hypertension or
hypercholesterolaemia,
postmenopausal hormone use,
glycaemic index and Mg
Q1 319 v. Q5 303
Q1 67·2 v. Q5
68·1
Q1 2603 v. Q5
2462

P < 0·001

P < 0·001

P = 0·007

E. M. Barrett et al.

Qi, 2006(17)

PCS

Added† N/A

Covariates

P = 0·11
P = 0·86
P = 0·06

Downloaded from https://www.cambridge.org/core. University of Wollongong, on 25 Mar 2019 at 22:55:33, subject to the Cambridge Core terms of use, available at https://www.cambridge.org/core/terms. https://doi.org/10.1017/S000711451900031X

Table 4. Continued
Study first author, year
(reference)
Wu, 2015

(18)

Cohort

Participants

Country Outcome

Bran

Highest
intake

Lowest
intake

PCS

NHS I and
HPFS

74 341 F,
43 744 M

USA

Total

N/A

N/A

Added

≥ 6·0 g/d

0 g/d

Total

N/A

N/A

Added

≥ 6·0 g/d

0 g/d

Total

9·6 g/d

0·6 g/d

Total

12·0 g/d

1·1 g/d

CVD death

All-cause death

De Munter, 2007(19)

PCS

NHS I

167 737 F

USA

T2DM

NHS II
Flint, 2009

(20)

Koh-Banerjee, 2004(21)

PCS

HPFS

31 684 M

USA

Hypertension

Total

12·0 g/d

0·3 g/d

PCS

HPFS

27 082 M

USA

8-year weight
change (kg)

Added

7·3 g/d
change

0·0 g/d

Covariates

Results

HR 0·80 (95 % CI
Age, ethnicity, BMI, smoking status,
0·73, 0·87)
pack years smoked, years since
quitting for past smoker, alcohol
intake, physical activity, family
history of diabetes, cancer and
heart disease, multivitamin use,
aspirin use at least once per week,
history of hypertension, high
cholesterol or diabetes at baseline,
total energy intake, postmenopausal
status and postmenopausal
hormone use (for women), modified
alternative healthy eating index
(excludes whole grains)
HR 0·76 (95 % CI
0·70, 0·83)‡
HR 0·94 (95 % CI
0·90, 0·99)§
HR 0·93 (95 % CI
0·89, 0·97)‡
Age, smoking status, physical activity, RR 0·72 (95 % CI
0·65, 0·80)
alcohol intake, use of hormone
replacement therapy, oral
contraceptive use, family history of
T2DM, intake of coffee, sugarsweetened soft drinks and fruit
punch (non-alcoholic), total energy
intake, processed meat intake,
PUFA:saturated fat intake ratio, BMI
RR 0·84 (95 % CI
0·71, 1·00)
Age, energy intake, family history of RR 0·85 (95 % CI
0·78, 0·92)
CHD and hypertension, smoking
status, alcohol intake, marital
status, profession, height, fruit
and vegetable intake, Na intake,
physical activity, multivitamin use,
cholesterol screening
Q1 1·16 (SD 0·23) v.
Age, baseline exposure, smoking
status, baseline weight, baseline
Q3 1·00 (SD 0·20)
values and changes in refined
grains, total energy intake,
physical activity, alcohol intake,
protein intake and trans,
saturated, MUFA and PUFA
intake, baseline and changes in
natural bran

P
P < 0·001

P < 0·001
P = 0·02
P = 0·006
P < 0·001

Whole grains and CVD

Study

P = 0·07
P = 0·002

P = 0·01

9

PCS, prospective cohort study; NHS, Nurses’ Health Study; F, female; T2DM, type 2 diabetes mellitus; MI, myocardial infarction; RR, relative risk; N/A, not available; HPFS, Health Professionals Follow-up Study; M, male; HR, hazard ratio;
CRP, C-reactive protein; ICAM-1, intercellular adhesion molecule 1; TNF-R2, TNF receptor 2.
* Bran consumed naturally within whole grains and bran added to food/consumed separately.
† Bran added to food/consumed separately only.
‡ Located within Wu et al.(18) online Supplementary Table S7.
§ Located within Wu et al.(18) online Supplementary Table S6.
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Table 5. Characteristics of studies within expanded analysis exploring associations of whole grain intake with outcomes related to CVD
Study first author,
year (reference)
Jensen, 2006

(22)

Study

Cohort

Participants

Country

Outcome

Cross-sectional

HPFS and NHS II

468 M + 470 F

USA

Total cholesterol
(mmol/l)

Highest
intake

Lowest
intake

43·8 g/d

8·2 g/d

HDL-cholesterol
(mmol/l)
LDL-cholesterol
(mmol/l)
HbA1c (%)

Insulin (pmol/l)
C-peptide (ng/ml)
Leptin (ng/ml)

Fibrinogen (g/l)
IL-6 (pg/ml)

Liu, 1999

(23)

Juan, 2017(24)

PCS

PCS

NHS I

NHS I and HPFS

75 521 F

71 750 F + 42 823 M

USA

USA

Homocysteine
(µmol/l)
CHD

Stroke

2·70
serves/d*

F: 33·23 g/d

0·13
serves/d

F: 4·43 g/d

Results

Age, sex, total energy intake, Q1 5·7 (SE 0·08) v.
alcohol intake, smoking
Q5 5·6 (SE 0·07)
status, BMI, physical activity,
hypercholesterolaemia,
intake of fruit, vegetable,
saturated fat, MUFA and
PUFA
Q1 1·7 (SE 0·03) v.
Q5 1·6 (SE 0·03)
Q1 3·3 (SE 0·07) v.
Q5 3·2 (SE 0·06)
Age, sex, total energy intake, Q1 5·50 (SE 0·04) v.
Q5 5·49 (SE 0·04)
alcohol intake, smoking
status, BMI, physical activity,
hypercholesterolaemia,
intake of fruit, vegetable,
sucrose and fructose
Q1 91·7 (SE 4·9) v.
Q5 78·5 (SE 5·6)
Q1 2·13 (SE 0·08) v.
Q5 1·84 (SE 0·08)
Q1 9·02 (SE 1·03) v.
Q5 8·03 (SE 1·04)
Q1 0·92 (SE 1·07) v.
Q5 0·88 (SE 1·07)
Q1 2·2 (SE 0·03) v.
Q5 2·2 (SE 0·03)
Q1 1·20 (SE 1·04) v.
Q5 1·13 (SE 1·05)
Q1 13·2 (SE 0·6) v.
Q5 10·9 (SE 0·3)
Age, BMI, smoking status,
RR 0·75 (95 % CI
alcohol intake, family history
0·59, 0·95)
of MI before 60 years, selfreported history of
hypertension or
hypercholesterolaemia,
menopausal status, protein
intake, aspirin use, use of
multiple vitamin or vitamin E
supplements, vigorous
activity, total energy intake
and saturated fat, MUFA,
PUFA and trans fat intake
Whole grain constituent intake: RR 0·79 (95 % CI
0·62, 1·01)
dietary fibre, folate, vitamin
B6 and vitamin E
Age, BMI, smoking status,
HR 1·03 (95 % CI
alcohol intake, physical
0·88, 1·21)
activity, family history of
diabetes mellitus, cancer
and heart disease,
multivitamin use,
hypertension or high
cholesterol at baseline, total
energy intake, modified
alternative eating index
score (did not include whole
grains), menopausal status
and postmenopausal
hormone use

P
P = 0·02

P = 0·05
P = 0·10
P = 0·83

P = 0·13
P = 0·03
P = 0·03
P = 0·63
P = 0·77
P = 0·87
P < 0·001
P = 0·01

E. M. Barrett et al.

CRP (mg/l)

Covariates

P = 0·07
P = 0·35
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Table 5. Continued
Study first author,
year (reference)

Fung, 2002(25)

Montonen, 2003

Meyer, 2000

(27)

Study

PCS

(26)

PCS

PCS

HPFS

FMC

Participants

42 898 M

4316 F + M

Country

USA

Finland

Outcome

T2DM

T2DM

Highest
intake

Lowest
intake

M: 47·90 g/d

M: 5·92 g/d

N/A

N/A

3·2 serves/d

0·4 serves/d

302 g/d

79 g/d

IWHS

35 988
postmenopausal F

USA

T2DM

20·5 serves/
week

1·0 serves/
week

FOS

2834 M + F

USA

Mean HOMA-IR

20·4 serves/
week

0·9 serves/
week

Metabolic
syndrome

Huang, 2015(29)

PCS

NIH-AARP Diet
and Health
Study

367 442 M + F

USA

CVD death

All-cause death

1·20 oz/d

0·13 oz/d

Covariates

Results
HR 1·06 (95 % CI
0·85, 1·32)
Pooled HR 1·04
(95 % CI 0·91,
1·19)
RR 0·70 (95 % CI
0·57, 0·85)

P = 0·37
P = 0·97
P = 0·0006

P = 0·98
P = 0·02

P = 0·63
P = 0·0089

P = 0·46
P = 0·05

P = 0·34
P = 0·01

P = 0·20
P < 0·001

P = 0·19
P < 0·0001

P = 0·002

11

Age, time period, physical
activity, energy intake,
missing FFQ, smoking
status, family history of
diabetes, alcohol intake, fruit
intake, vegetable intake and
BMI
Cereal fibre intake
RR 0·98 (95 % CI
0·76, 1·26)
Age, sex, geographic area,
RR 0·65 (95 % CI
energy intake, smoking
0·36, 1·18)
status, BMI and intake of
fruit, berries and vegetables
Cereal fibre intake
RR 1·14 (95 % CI
0·49, 2·66)
Age, total energy intake, BMI, RR 0·79 (95 % CI
waist:hip ratio, education,
0·65, 0·96)
smoking status, alcohol
intake and physical activity
Cereal fibre intake
RR 0·93 (95 % CI
0·75, 1·16)
Age, sex, BMI, waist:hip ratio, Q1 6·8 (6·6, 7·1) v.
smoking status, total energy
Q5 6·6 (6·4, 6·9)
intake, alcohol intake,
percentage saturated fat,
percentage PUFA,
multivitamin use, physical
activity and treatment for BP
Cereal fibre intake
Q1 6·8 v. Q5 6·7
Sex, age, smoking status, total OR 0·67 (95 % CI
energy intake, alcohol
0·48, 0·91)
intake, percentage saturated
fat, percentage PUFA,
multivitamin use and
physical activity
Cereal fibre intake
OR 0·77 (95 % CI
0·55, 1·09)
Age, sex, smoking status, race/ HR 0·83 (95 % CI
ethnicity group, alcohol
0·78, 0·88)
intake, education level,
marital status, health status,
obesity, physical activity,
intake of red meat, fruit and
vegetable, total energy
intake and hormone usage
Cereal fibre intake
HR 0·95 (95 % CI
0·88, 1·03)
Age, sex, smoking status, race/ HR 0·83 (95 % CI
ethnicity group, alcohol
0·81, 0·86)
intake, education level,
marital status, health status,
obesity, physical activity,
intake of red meat, fruit and
vegetable, total energy
intake and hormone usage
Cereal fibre intake
HR 0·94 (95 % CI
0·90, 0·97)

P

Whole grains and CVD

McKeown, 2004(28) Cross-sectional

Cohort
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Table 5. Continued
Study first author,
year (reference)
Jacobs, 2000

Erkkila, 2005

(30)

(31)

Cohort

Participants

Country

Outcome

PCS

IWHS

11 040
postmenopausal F

USA

CHD death

PCS

Cross-sectional

ERA

BLSA

229 postmenopausal F USA
with coronary
atherosclerosis

1516 F + M

USA

Highest
intake

Lowest
intake

Covariates

Results

4·7 g whole
1·3 g whole
Age, energy intake,
HR 0·89 (95 % CI
grain fibre/
grain fibre/
educational status, marital
0·66, 1·20)
8368 kJ
8368 kJ
status, hypertension,
(2000
(2000
diabetes, heart disease,
kcal)
kcal)
cancer, BMI, waist:hip ratio,
age at first birth, physical
activity score, smoking
status, pack years of
cigarette smoking, alcohol
intake, vitamin supplement
use, hormone replacement
therapy use, percentage
energy from total fat,
saturated fat and
carbohydrates, intake per
4184 kJ (1000 kcal) of fibre
from non-grain sources, intake
of red meat, fish and seafood
Other CVD death
HR 0·75 (95 % CI
0·54, 1·06)
All-cause death
HR 0·83 (95 % CI
0·73, 0·94)
Change in min.
>6 serves/
≤6 serves/
Age, location of coronary
Lowest intake:
coronary artery
week
week
segment, BMI, smoking
–0·10 (SD 0·02) v.
highest intake:
diameter (mm)
status, use of cholesterol–0·06 (SD 0·02)
lowering medication and
hormone replacement
therapy, diabetes, education,
clinic, time of follow-up,
alcohol intake, coronary
artery bypass, percutaneous
transluminal coronary
angioplasty, energy intake,
saturated fat, PUFA and
cholesterol intake, serum
total, HDL- and LDLcholesterol, TAG and
systolic BP
Change stenosis
Lowest intake: 3·62
(%)
(SD 0·86) v.
highest intake:
1·69 (SD 0·90)
Diastolic BP
45·4 g/d
0·62 g/d
Age, age2, sex, total energy
Q1 79·8 (SE 0·6) v.
(mmHg)
intake, decade of visit, race,
Q5 79·2 (SE 0·7)
education, vitamin
supplement use, smoking
status, percentage energy
from saturated fat, alcohol
and refined grains, BMI, use
of BP medication and
hypertension
Systolic BP
Q1 129·2 (SE 1·0) v.
Q5 128·3 (SE 1·0)
(mmHg)
2
Total cholesterol
45·6 g/d
0·63 g/d
Age, age , sex, total energy
Q1 5·71 (SE 0·06) v.
intake, decade of visit, race,
Q5 5·49 (SE 0·06)
(mmol/l)
education, vitamin
supplement use, smoking
status, percentage energy
from saturated fat, alcohol
and refined grains, BMI, use
of lipid-lowering medication
and hypercholesterolaemia

P
P > 0·05

P > 0·05
P < 0·05
P = 0·04

E. M. Barrett et al.

Newby, 2007(32)

Study

P = 0·09

P = 0·42

P = 0·79
P = 0·02
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Table 5. Continued
Study first author,
year (reference)

Study

Cohort

Participants

Country

Highest
intake

Lowest
intake

HDL-cholesterol
(mmol/l)
LDL-cholesterol
(mmol/l)
TAG (mmol/l)

54·0 g/d

4·1 g/d

54·8 g/d

3·9 g/d

Fasting glucose
(mmol/l)

45·4 g/d

Outcome

2 h glucose
50·6 g/d
(mmol/l)
Fasting insulin
51·5 g/d
(pmol/l)
2 h insulin (pmol/l) 51·7 g/d
2

46·0 g/d

1·1 g/d
2·2 g/d
2·4 g/d
0·65 g/d

Weight (kg)

McKeown, 2009(33) Cross-sectional

3 year trial (vitamin 324 M + F
K and bone loss)

USA

Waist
circumference
(cm)
BMI (kg/m2)

49·3 g/d

0·94 g/d

2·86
serves/d

0·21
serves/d

Body fat (%)
Trunk fat mass (%)
Van de Vijver,
2007(34)

Cross-sectional

NLCS

4237 M + F

Netherlands BMI (kg/m2)

Overweight risk

Obesity risk

N/A

N/A

Results

Q1 1·27 (SE 0·02) v.
Q5 1·22 (SE 0·02)
Q1 3·16 (SE 0·06) v.
Q5 2·96 (SE 0·06)
Q1 1·23 (SE 0·05) v.
Q5 1·16 (SE 0·05)
Age, age2, sex, total energy
Q1 5·49 (SE 0·06) v.
intake, decade of visit, race,
Q5 5·49 (SE 0·06)
education, vitamin
supplement use, smoking
status, percentage energy
from saturated fat, alcohol
and refined grains, BMI, oral
hypoglycaemic medication
and diabetes
Q1 8·24 (SE 0·17) v.
Q5 7·32 (SE 0·17)
Q1 71·6 (SE 3·9) v.
Q5 71·8 (SE 4·1)
Q1 479 (SE 38·0) v.
Q5 414 (SE 39·1)
Age, age2, sex, total energy
Q1 25·5 (SE 0·2) v.
intake, decade of visit, race,
Q5 24·8 (SE 0·2)
education, vitamin
supplement use, smoking
status, percentage energy
from saturated fat, alcohol
and refined grains
Q1 75·0 (SE 0·7) v.
Q5 72·6 (SE 0·2)
Q1 87·4 (SE 0·6) v.
Q5 85·0 (SE 0·6)
Age, sex, total energy intake, Q1 26·8 (25·7,
percentage energy from fat,
28·1) v. Q4 25·8
physical activity, smoking
(24·6, 27·1)
status, alcohol intake and
multivitamin use
Q1 34·5 (32·7,
36·3) v. Q4 32·1
(30·1, 34·1)
Q1 43·0 (40·4,
45·5) v. Q4 39·4
(36·7, 42·1)
Age, energy intake, intake of
M: β –0·03 (–0·05,
animal protein, education,
–0·02)
smoking status, number of F: β –0·04 (–0·06,
cigarettes, intake of fruit and
–0·01)
vegetables
M: OR 0·98 (95 %
CI 0·96, 0·99)
F: OR 0·98 (95 %
CI 0·96, 0·99)
M: OR 0·90 (95 %
CI 0·84, 0·98)
F: OR 0·96 (95 %
CI 0·93, 0·99)

P
P = 0·07
P = 0·04
P = 0·22
P = 0·57

P = 0·006
P = 0·90
P = 0·43
P < 0·0001

P = 0·004
P = 0·002
P = 0·08

Whole grains and CVD

BMI (kg/m )

0·56 g/d

Covariates

P = 0·02
P = 0·02
P < 0·01
P < 0·01
P < 0·01
P < 0·01
P < 0·05
P < 0·05

13

HPFS, Health Professionals Follow-up Study; NHS, Nurses’ Health Study; M, male; F, female; CRP, C-reactive protein; PCS, prospective cohort study; MI, myocardial infarction; RR, relative risk; HR, hazard ratio; T2DM, type 2 diabetes
mellitus; FMC, Finnish Mobile Clinic Health Examination Survey; IWHS, Iowa Women’s Health Study; FOS, Framingham Offspring Study; HOMA-IR, homoeostatic model assessment of insulin resistance; ERA, Estrogen Replacement
and Atherosclerosis trial; BLSA, Baltimore Longitudinal Study of Aging; BP, blood pressure; NLCS, Netherlands Cohort Study; N/A, not available.
* One whole grain serve (s): one slice bread; one cup breakfast cereal, rice, pasta, other grain, popcorn, cooked oatmeal; one tablespoon bran, wheat germ.
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Table 6. Characteristics of studies within expanded analysis exploring associations of cereal fibre intake with outcomes related to CVD
Study first author,
year (reference)
Montonen, 2003

(26)

Meyer, 2000(27)

McKeown, 2004

(28)

Cohort

Participants

Cou-ntry

Outcome

Highest intake

Lowest intake

Covariates

PCS

FMC

4316 F + M

Finland

T2DM

24·5–111 g/d

0·47–12·0 g/d

PCS

IWHS

35 988 F

USA

T2DM

9·43 g/d

2·66 g/d

Age, sex, geographic area,
RR 0·39 (95 % CI
energy intake, smoking
0·20, 0·77)
status, BMI and intake of
fruit, berries and vegetables
Age, total energy intake, BMI, RR 0·64 (95 % CI
waist:hip ratio, education,
0·53, 0·79)
smoking status, alcohol
intake and physical activity
Whole grain intake
RR 0·66 (95 % CI
0·53, 0·83)
Age, sex, BMI, waist:hip ratio, Q1 6·8 (6·5, 7·0) v.
smoking status, total energy
Q5 6·6 (6·3, 6·8)
intake, alcohol intake,
percentage saturated fat,
percentage PUFA,
multivitamin use, physical
activity and treatment for
blood pressure
Whole grain intake
Q1 6·9 v. Q5 6·5
Sex, age, smoking status, total OR 0·62 (95 % CI
energy intake, alcohol
0·45, 0·86)
intake, percentage saturated
fat, percentage PUFA,
multivitamin use and
physical activity
Age, sex, smoking status, race/ HR 0·80 (95 % CI
ethnicity group, alcohol
0·75, 0·85)
intake, education level,
marital status, health status,
obesity, physical activity,
intake of red meat, fruit and
vegetable, total energy
intake and hormone usage
HR 0·81 (95 % CI
0·79, 0·84)
Age, location of coronary
Lowest: –0·09 v.
segment, BMI, smoking
highest: –0·04
status, use of cholesterollowering medication and
hormone replacement
therapy, diabetes, education,
clinic, time of follow-up,
alcohol intake, coronary
artery bypass, percutaneous
transluminal coronary
angioplasty, energy intake,
saturated fat, PUFA and
cholesterol intake, serum
total, HDL-, and LDLcholesterol, TAG and
systolic blood pressure
Lowest: 3·44 v.
highest: 1·79

Cross-sectional FOS

2834 M + F

USA

Mean HOMA-IR

8·0 g/d

2·6 g/d

Metabolic
syndrome

Huang, 2015(29)

PCS

NIH-AARP
Diet and
Health
Study

367 442 M + F

Erkkila, 2005(31)

PCS

ERA

229 postmenopausal USA
F with coronary
atherosclerosis

USA

CVD death

10·22 g/d

2·02 g/d

All-cause death
Change in min.
>3 g/4184 kJ
coronary artery
(1000 kcal)
diameter (mm)

Change stenosis
(%)

≤3 g/4184 kJ
(1000 kcal)

Results

P
P = 0·01

P = 0·0001

P = 0·0001
P = 0·02

P = 0·003
P = 0·002

P < 0·0001

E. M. Barrett et al.

Study

P < 0·0001
P = 0·03

P = 0·10

Downloaded from https://www.cambridge.org/core. University of Wollongong, on 25 Mar 2019 at 22:55:33, subject to the Cambridge Core terms of use, available at https://www.cambridge.org/core/terms. https://doi.org/10.1017/S000711451900031X

Table 6. Continued
Study first author,
year (reference)
Newby, 2007

(32)

Study

Cohort

Cross-sectional BLSA

Participants
1516 F + M

Cou-ntry
USA

Outcome
Diastolic BP
(mmHg)

Systolic BP
(mmHg)
Total cholesterol
(mmol/l)

Fasting glucose
(mmol/l)

Lowest intake

9·43 g/d

2·19 g/d

9·56 g/d

2·2 g/d

11·49 g/d

2·9 g/d

9·58 g/d

2·2 g/d

9·67 g/d

2·27 g/d

2 h glucose
10·42 g/d
(mmol/l)
Fasting insulin
11·63 g/d
(pmol/l)
2 h insulin (pmol/l)

2·39 g/d

BMI (kg/m2)

2·19 g/d

9·51 g/d

2·54 g/d

Weight (kg)
Waist
circumference
(cm)

9·74 g/d

2·31 g/d

Covariates
2

Results

Age, age , sex, total energy
Q1 79·5 (SE 0·8) v.
intake, decade of visit, race,
Q5 79·2 (SE 0·8)
education, vitamin
supplement use, smoking
status, percentage energy
from saturated fat and
alcohol, BMI, use of blood
pressure-lowering
medication and
hypertension
Q1 128·7 (SE 1·0) v.
Q5 129·7 (SE 1·0)
Age, age2, sex, total energy
Q1 5·73 (SE 0·06) v.
intake, decade of visit, race,
Q5 5·44 (SE 0·06)
education, vitamin
supplement use, smoking
status, percentage energy
from saturated fat and
alcohol, BMI, use of lipidlowering medication and
hypercholesterolaemia
Q1 1·23 (SE 0·02) v.
Q5 1·25 (SE 0·02)
Q1 3·13 (SE 0·06) v.
Q5 2·99 (SE 0·06)
Q1 1·24 (SE 0·05) v.
Q5 1·15 (SE 0·05)
Age, age2, sex, total energy
Q1 5·55 (SE 0·05) v.
intake, decade of visit, race,
Q5 5·52 (SE 0·05)
education, vitamin
supplement use, smoking
status, percentage energy
from saturated fat and
alcohol, BMI, oral
hypoglycaemic medication
and diabetes
Q1 8·05 (SE 0·21) v.
Q5 6·48 (SE 0·21)
Q1 68·9 (SE 4·0) v.
Q5 73·0 (SE 4·0)
Q1 438 (SE 38·8) v.
Q5 413 (SE 38·2)
Age, age2, sex, total energy
Q1 25·7 (SE 0·2) v.
intake, decade of visit, race,
Q5 24·3 (SE 0·2)
education, vitamin
supplement use, smoking
status, percentage energy
from saturated fat, alcohol
and refined grains
Q1 75·6 (SE 0·7) v.
Q5 71·4 (SE 0·8)
Q1 87·4 (SE 0·6) v.
Q5 84·1 (SE 0·6)

P
P = 0·90

P = 0·27
P = 0·005

P = 0·59
P = 0·07
P = 0·12
P = 0·95

Whole grains and CVD

HDL-cholesterol
(mmol/l)
LDL-cholesterol
(mmol/l)
TAG (mmol/l)

Highest intake

P = 0·02
P = 0·68
P = 0·33
P < 0·0001

P = 0·0004
P < 0·0001
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Table 6. Continued
Study first author,
year (reference)
McKeown 2009

(33)

Study

Cohort

Cross-sectional 3 year trial
(vitamin K
and bone
loss)

Participants
324 M + F

Cou-ntry
USA

Outcome
2

BMI (kg/m )

Lowest intake

Covariates

9·3 g/d

2·4 g/d

Age, sex, total energy intake, Q1 27·3 (26·1,
percentage energy from fat,
28·6) v. Q4 25·4
physical activity, smoking
(24·2, 26·7)
status, alcohol intake and
multivitamin use
Q1 34·7 (32·8,
36·6) v. Q4 31·5
(29·4, 33·5)
Q1 42·8 (40·2,
45·4) v. Q4 37·8
(35·0, 40·6)
Age, energy intake, intake of
M: b –0·04
animal protein, education,
(–0·06, –0·02)
smoking status, number of F: b 0·01
cigarettes, intake of fruits
(–0·03, 0·05)
and vegetables
M: OR 0·98 (95 %
CI 0·96, 0·99)
F: OR 1·00 (95 %
CI 0·97, 1·02)
M: OR 0·97 (95 %
CI 0·92, 1·02)
F: OR 1·03 (95 %
CI 0·98, 1·07)

Body fat (%)
Trunk fat mass (%)
Van de Vijver
2007(34)

Cross-sectional NLCS

4237 M + F

Nether-lands BMI (kg/m2)

Overweight risk

Obesity risk

N/A

N/A

Results

P
P = 0·01

P = 0·004
P = 0·001
P < 0·01
P > 0·05
P < 0·01
P > 0·05
P > 0·05
P > 0·05

PCS, prospective cohort study; FMC, Finnish Mobile Clinic Health Examination Survey; F, female; M, male; T2DM, type 2 diabetes mellitus; RR, relative risk; IWHS, Iowa Women’s Health Study; FOS, Framingham Offspring Study; HOMAIR, homoeostatic model assessment of insulin resistance; HR, hazard ratio; ERA, Estrogen Replacement and Atherosclerosis trial; BLSA, Baltimore Longitudinal Study of Aging; BP, blood pressure; NLCS, Netherlands Cohort Study; N/
A, not available.

E. M. Barrett et al.

Highest intake
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Table 7. Characteristics of studies within expanded analysis exploring associations of bran intake with outcomes related to CVD
Study first author, year
(reference)
Jensen, 2006

(22)

Study

Cohort

CrossHPFS and
sectional
NHS II

Participants

Country Outcome

468 M + 470 F USA

HbA1c (%)

Bran

Highest intake Lowest intake Covariates

Total*

13·56 g/d

1·42 g/d

Insulin (pmol/l)
C-peptide (ng/ml)
Leptin (ng/ml)
Total cholesterol
(mmol/l)

Fibrinogen (g/l)
IL-6 (pg/ml)

Liu, 1999(23)

PCS

NHS I

75 521 F

USA

Homocysteine
(µmol/l)
CHD

Juan, 2017(24)

PCS

NHS I and
HPFS

71 750
F + 42 823
M

USA

Stroke

Added† 1·0 serves/d‡

0 serves/d

Total

F: 1·10 g/d

F: 8·50 g/d

P = 0·53

P = 0·14
P = 0·05
P = 0·88
P = 0·06

P = 0·06
P = 0·13
P = 0·08
P = 0·87
P = 0·82
P = 0·02
P = 0·001

P = 0·62
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Q1 5·45 (SE 0·04) v.
Age, sex, smoking status,
BMI, physical activity,
Q5 5·50 (SE 0·05)
hypercholesterolaemia,
alcohol intake, total energy
intake, intake of fruits,
vegetables, germ, sucrose
and fructose
Q1 86·8 (SE 4·9) v.
Q5 76·4 (SE 3·5)
Q1 2·11 (SE 0·10) v.
Q5 1·84 (SE 0·06)
Q1 8·67 (SE 1·04) v.
Q5 8·5 (SE 1·04)
Q1 5·8 (SE 0·09) v.
Age, sex, smoking status,
Q5 5·6 (SE 0·07)
BMI, physical activity,
hypercholesterolaemia,
alcohol intake, total energy
intake, intake of fruits,
vegetables, germ,
saturated fat, MUFA and
PUFA
Q1 1·7 (SE 0·03) v.
Q5 1·6 (SE 0·03)
Q1 3·3 (SE 0·08) v.
Q5 3·2 (SE 0·06)
Q1 0·99 (SE 1·09) v.
Q5 0·77 (SE 1·08)
Q1 2·2 (SE 0·03) v.
Q5 2·2 (SE 0·03)
Q1 1·13 (SE 1·05) v.
Q5 1·13 (SE 1·13)
Q1 12·9 (SE 0·5) v.
Q5 11·5 (SE 0·4)
BMI, smoking status, alcohol RR 0·63 (95 % CI
0·42, 0·95)
intake, family history of MI
before 60 year, selfreported history of
hypertension or
hypercholesterolaemia,
menopausal status,
protein intake, aspirin use,
use of multiple vitamin or
vitamin E supplements,
vigorous activity and total
energy intake
HR 1·00 (95 % CI
Age, BMI, smoking status,
0·86, 1·16)
alcohol intake, physical
activity, family history of
diabetes mellitus, cancer
and heart disease,

P

Whole grains and CVD

HDL-cholesterol
(mmol/l)
LDL-cholesterol
(mmol/l)
CRP (mg/l)

Results
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N/A
N/A

M: 11·91 g/d

M: 1·30 g/d

multivitamin use,
hypertension or high
cholesterol at baseline,
total energy intake,
modified alternative eating
index score (did not
include whole grains),
menopausal status and
postmenopausal hormone
use

HPFS, Health Professionals Follow-up Study; NHS, Nurses’ Health Study; M, male; F, female; CRP, C-reactive protein; PCS, prospective cohort study; RR, relative risk; HR, hazard ratio.
* Bran consumed naturally within whole grains and bran added to food/consumed separately.
† Bran added to food/consumed separately only.
‡ One serve(s) of bran = one tablespoon.

Study first author, year
(reference)

Table 7. Continued

Study

Cohort

Participants

Country Outcome

Bran

Highest intake Lowest intake Covariates

Results

P

HR 0·73 (95 % CI P < 0·001
0·60, 0·88)
P = 0·004
Pooled HR 0·89
(95 % CI 0·79,
1·00)

E. M. Barrett et al.

T2DM among healthy participants within the NHS I (relative risk
(RR) 0·75, 95 % CI 0·68, 0·83, P < 0·001 and RR 0·72, 95 % CI
0·65, 0·80, P < 0·001, respectively) and the NHS II (RR 0·86, 95 %
CI 0·72, 1·02, P = 0·03 and RR 0·84, 95 % CI 0·71, 1·00, respectively)(19); however, the inverse association with total bran
intake within the NHS II only reached borderline signiﬁcance
(P = 0·07).
Whole grain intake was associated with a 19 % lower risk of
hypertension(20) (RR 0·81, 95 % CI 0·75, 0·87, P < 0·0001) and a
16 % lower risk of CHD(5) (HR 0·84, 95 % CI 0·71, 0·98, P = 0·02)
in the HPFS, when comparing the highest quartile of intake to
lowest. However, after adjusting for cereal ﬁbre intake(20) and
whole grain constituents including dietary ﬁbre(5), both of these
association were attenuated (P = 0·23 and P = 0·06, respectively), suggesting some signiﬁcance of the cereal ﬁbre component towards the whole grain association. Bran intake was
also inversely associated with risk of both hypertension and
CHD (RR 0·85, 95 % CI 0·78, 0·92, P = 0·002 and HR 0·72, 95 %
CI 0·61, 0·84, P < 0·001, respectively), and the association with
lower risk of CHD remained signiﬁcant after adjusting for
constituents (P < 0·001).

Whole grain intake compared with bran and cereal ﬁbre
intake. Within the HPFS, whole grain, bran and cereal ﬁbre
intake were associated with better weight management over
time(21). The association was stronger for whole grain intake
than for cereal ﬁbre or bran intake. For every 40 g/d increase in
whole grain intake, 8-year weight gain was 1·1 kg lower
(P < 0·0001), while for every 20 g/d increase in cereal ﬁbre or
bran intake, 8-year weight gain was 0·81 kg (P = 0·0002) and
0·36 kg lower (P = 0·01), respectively, indicating a slightly
stronger association for whole grain intake.
Lower risks of CVD mortality and all-cause mortality were
found for high whole grain, cereal ﬁbre and bran (total and
added) intake in a cohort of 7822 women with existing
T2DM(4). However, after adjustment for lifestyle and dietary
factors, only the associations for total and added bran intake
remained signiﬁcant for both outcomes. A 64 % lower risk of
CVD mortality (RR 0·36, 95 % CI 0·24, 0·54, P < 0·001) and a
55 % lower risk of all-cause mortality (RR 0·45, 95 % CI 0·36,
0·57, P < 0·001) were observed for those consuming the highest
intake of added bran compared with non-consumers.
Whole grain, bran and cereal ﬁbre were signiﬁcantly inversely related to C-reactive protein (CRP) and TNF receptor 2
levels in a fair quality analysis of women with T2DM within the
NHS I(17), but no association was found with E-selectin or
intercellular adhesion molecule 1 levels. Notably, within this
study no adjustment was made for other dietary factors that may
be correlated with whole grain intake and inﬂuence inﬂammation, such as PUFA intake.

Expanded analysis
Eleven of thirteen articles within the expanded analysis found a
signiﬁcant inverse association between whole grain intake and
at least one CVD-related outcome analysed(22,23,25–29,31–34),
though six of these found the association no longer signiﬁcant
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Table 8. Classification of study design as per National Health and Medical Research Council (NHMRC) level of evidence guidelines and classification of quality as per National Institutes of Health (NIH) quality
assessment tool for observational cohort and cross-sectional studies

Reference
Initial analysis
He (2010)(4)
Jensen (2004)(5)
Qi (2006)(17)
Wu (2015)(18)
de Munter (2007)(19)
Flint (2009)(20)
Koh Banerjee (2004)(21)
Expanded analysis
Jensen (2006)(22)
Liu (1999)(23)
Juan (2017)(24)
Fung (2002)(25)
Montonen (2003)(26)
Meyer (2000)(27)
McKeown (2004)(28)
Huang (2015)(29)
Jacobs (2000)(30)
Erkkila (2005)(31)
Newby (2007)(32)
McKeown (2009)(33)
Van de Vijver (2009)(34)

NHMRC level
of evidence

NIH quality assessment
tool rating

II
II
IV
II
II
III-2
II

Good
Good
Fair
Good
Good
Good
Good

IV
II
II
II
II
II
IV
II
II
III-2
IV
IV
IV

Fair
Good
Good
Good
Fair
Fair
Fair
Good
Fair
Fair
Fair
Fair
Fair

after adjustment for cereal ﬁbre intake(23,25–29), indicating cereal
ﬁbre as a key component in the association. All eight articles
that analysed cereal ﬁbre intake separately found a signiﬁcant
inverse association with at least one CVD-related outcome(26–29,31–34). One article investigating bran intake found
mixed association(22), while the other two found signiﬁcant
inverse association(23,24).

Whole grain intake compared with bran intake. One fair
quality analysis(22) considered association of whole grain and
bran intake with lipid proﬁle, markers of glycaemic control and
inﬂammation. The highest consumers of whole grains (quintile
5; Q5) had 2·9 % lower total cholesterol (P = 0·02), 5·3 % lower
HDL-cholesterol (P = 0·05) and 2·1 % lower LDL-cholesterol
than the lowest consumers (quintile 1; Q1), although the
association with LDL-cholesterol did not reach signiﬁcance
(P = 0·10). Highest whole grain intake (Q5) was also associated
with 17·4 % lower levels of homocysteine as well as lower
concentrations of C-peptide (–13·6 %, P = 0·03) and leptin (–
11·0 %, P = 0·03). Other markers examined, including HbA1c,
were not associated with whole grain intake. Similar associations were seen when examining bran intake separately but
were only borderline statistically signiﬁcant, with the exception
of homocysteine concentrations (–10·9 %, P = 0·02). Leptin was
not associated with bran intake (–2·0 %, P = 0·88).
Whole grain and bran intake were both associated with lower
incidence of CHD in a good quality prospective cohort study(23)
(RR 0·75, 95 % CI 0·59, 0·95, P = 0·01 and RR 0·63, 95 % CI 0·42,
0·95, P = 0·001, respectively), with participants consuming one
serving of added bran per d observing a 37 % lower risk of CHD
compared with non-consumers. These signiﬁcant associations
were found after adjustment for several related lifestyle and diet
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covariates including smoking status, physical activity and fatty
acid composition of diet, however, the association with whole
grain intake was attenuated after further adjustment for grain
constituents including dietary ﬁbre (P = 0·07). High total bran
intake was associated with 11 % lower risk of stroke (HR 0·89,
95 % CI 0·79, 1·0, P = 0·004) in a separate good quality pooled
cohort study, whereas whole grain intake showed no
association(24).

Whole grain intake compared with cereal ﬁbre intake.
Whole grain intake was associated with a 21 % (95 % CI 0·65,
0·96, P = 0·0089) to 35 % (95 % CI 0·36, 1·18, P = 0·02) lower risk
of T2DM comparing the highest intake to the lowest intake in
three studies (one good quality, two fair quality)(25–27). Importantly, the two fair quality studies failed to adjust for potentially
important covariates including physical activity(26) and related
dietary factors such as fruit and vegetable intake(27). A fourth
study of fair quality found a 33 % lower risk (95 % CI 0·48, 0·91,
P = 0·01) of the metabolic syndrome(28). The association completely disappeared when adjusting for cereal ﬁbre in all four
cases. The three fair quality studies also observed association
for cereal ﬁbre intake separately and found that the highest
intake was associated with a 36 % (95 % CI 0·53, 0·79,
P = 0·0001) to 61 % (95 % CI 0·20, 0·77, P = 0·01) lower risk of
T2DM, and a 38 % (95 % CI 0·45, 0·86, P = 0·002) lower risk of
the metabolic syndrome. Meyer et al.(27) adjusted this result for
whole grain intake, and the lower risk was only slightly reduced
to 34 % (95 % CI 0·53, 0·83, P = 0·0001).
The association of whole grain and cereal ﬁbre intake with
all-cause mortality and CVD-mortality was explored in a large,
good quality analysis of 367 442 US participants(29). High whole
grain intake was associated with a 17 % lower risk of both
outcomes (95 % CI 0·81, 0·86, P < 0·0001 and 95 % CI 0·78, 0·88,
P < 0·001, respectively). Once adjusted for cereal ﬁbre, the
association with all-cause mortality was attenuated to 6 % (95 %
CI 0·90, 0·97, P = 0·002), and the association with CVD mortality
completely disappeared (HR 0·95, 95 % CI 0·88, 1·03, P = 0·188).
High cereal ﬁbre intake, analysed separately within the same
study, was associated with very similar lower risk of all-cause
and CVD mortality. In a smaller, fair quality study(30), whole
grain consumers tended to have lower risk of all-cause mortality
(HR 0·83, 95 % CI 0·73, 0·94, P < 0·05) compared with reﬁned
grain consumers.
The association of whole grain and cereal ﬁbre intake to
progression of coronary atherosclerosis among 229 women
were analysed within a fair quality study(31). Women consuming above the median intake of whole grains (>6 serves/week)
and cereal ﬁbre intake (>3 g/4184 kJ (1000 kcal)) had a signiﬁcantly smaller change in minimum coronary artery diameter
over the 3-year period compared with those consuming under
the median (–0·06 v. –0·10 mm, P = 0·04 and –0·04 v. –0·09 mm,
P = 0·03, respectively).
Two fair quality cross-sectional articles examined whole grain
and cereal ﬁbre intake in relation to glycaemic control. In the
Framingham Offspring Study, mean homoeostasis model
assessment-estimated insulin resistance (HOMA-IR) was borderline signiﬁcantly lower in the highest quintile of whole grain
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intake (quintile 5; Q5) compared with the lowest (quintile 1;
Q1) (Q1 6·8 v. Q5 6·6, P = 0·05); however, this association
disappeared once adjusted for cereal ﬁbre(28). In contrast, the
association between high cereal ﬁbre intake and lower mean
HOMA-IR remained after adjusting for whole grain intake (Q1
6·9 v. Q5 6·5, P = 0·003). Within the Baltimore Longitudinal
Study of Aging, higher whole grain and cereal ﬁbre intake were
similarly associated with lower postprandial glucose (quintile 1
(Q1) 8·24 mmol/l v. quintile 5 (Q5) 7·23 mmol/l, P = 0·006 and
Q1 8·05 mmol/l v. Q5 6·48 mmol/l, P = 0·02, respectively);
however, no association with fasting glucose, fasting insulin or
postprandial insulin were found(32).
Within the same study, the highest consumers of whole grain
and cereal ﬁbre had signiﬁcantly lower total cholesterol than the
lowest consumers (Q1 5·79 mmol/l v. Q5 5·49 mmol/l, P = 0·02
and Q1 5·73 mmol/l v. Q5 5·44 mmol/l, P = 0·005, respectively).
The highest consumers of both intake also had lower LDLcholesterol than the lowest consumers, though this was borderline signiﬁcant for cereal ﬁbre intake (Q1 3·13 mmol/l v. Q5
2·9 mmol/l, P = 0·07), and somewhat negatively, the highest
consumers of whole grain intake had lower HDL-cholesterol,
though not signiﬁcantly (Q1 1·27 mmol/l v. Q5 1·22 mmol/l,
P = 0·07).
Participants consuming the highest intake of whole grain and
cereal ﬁbre had signiﬁcantly lower anthropometric body measurements compared with those consuming the lowest intake in
three cross-sectional analyses(32–34), though notably two of the
three studies did not perform an adjustment for physical activity
within their multivariate models(32,34). Within the Netherlands
Cohort Study, it was estimated that every 1 g/d higher intake of
whole grain was associated with a 0·03 and 0·04 kg/m2 lower
BMI in men and women, respectively (P < 0·01 for both)(34).
This meant that a decrease of 1 kg/m2 BMI corresponded to a 33
and 25 g increase in whole grain intake. Every 1 g of cereal ﬁbre
intake was similarly associated with a 0·04 kg/m2 lower BMI in
men (P < 0·01), but no association was found for women.
Within the same cohort, a high intake of whole grain was
associated with a slightly lower risk of being overweight and
obese in both men (OR 0·98, 95 % CI 0·96, 0·99, P < 0·01 and OR
0·90, 95 % CI 0·84, 0·98, P < 0·05, respectively) and women (OR
0·98, 95 % CI 0·96, 0·99, P < 0·01 and OR 0·96, 95 % CI 0·93, 0·99,
P < 0·05, respectively), while a high intake of cereal ﬁbre was
only associated with a lower risk of being overweight in men
(OR 0·98, 95 % CI 0·96, 0·99, P <0·01). van de Vijver et al. also
conducted a prospective analysis of a smaller cohort of 1257
participants, with follow-up ranging 1–5 years, but no association was found between baseline intake and anthropometric
measures.

Discussion
Within the review, the association between whole grains, bran
and cereal ﬁbre and lower risk of CVD-related outcomes were
evident. In the expanded analysis, cereal ﬁbre and whole grain
(including added bran) intake were similarly associated with
lower risk of CVD mortality, and the ﬁbre component tended to
explain the association(29), whereas ﬁbre-rich bran was strongly

associated with lower risk of stroke incidence(24). The inverse
association between the risk of CVD-related outcomes and
cereal ﬁbre intake may be due to favourable effects on factors
likely to inﬂuence the development of the disease such as
serum lipids(35), glucose and insulin metabolism(36), blood
pressure(37) and inﬂammation(38). These factors may also play a
role in slowing progression of CVD, as higher intake of cereal
ﬁbre and whole grain products were both associated with less
progression of coronary atherosclerosis in postmenopausal
women with established CHD(31). The differences in progression (0·04 mm less progression in high whole grain consumers;
0·05 mm less progression in high cereal ﬁbre consumers) were
somewhat comparable with treatment effects reported in statin
trials (0·06–0·08 mm)(39).
Interestingly when studies assessed added bran intake (bran
added to food during processing), some of the strongest inverse
association with CVD-related outcomes were found. As added
bran, as opposed to total bran, does not include bran intake
consumed as part of whole grain foods, there is less chance of it
being simply a surrogate marker for whole grain intake, providing a more precise insight into the beneﬁts of bran alone. In
the study by He et al.(4) of women with T2DM, only added bran
was signiﬁcantly associated with lower CVD-related and allcause mortality after adjustment for related lifestyle and dietary
factors. While this study was underpowered to detect modest
associations; and therefore, the non-signiﬁcant associations
found for whole grain and cereal ﬁbre may be due to limited
power, the same strong inverse association with CVD mortality
and all-cause-mortality was found for added bran intake in
healthy participants(18). Furthermore, added bran had the
strongest inverse association with CHD(5,23). One possible
explanation for the consistently strong inverse associations
found for added bran is that within these populations, bran is
sourced mainly from only two sources, wheat bran and oat
bran(5). Oat bran is one of the highest sources of the soluble
ﬁbre β-glucan, which is consistently associated with reduced
serum total LDL-cholesterol in clinical trials(40,41).
However, the direct association within the cross-sectional
studies of whole grain, cereal ﬁbre and total bran intake to
serum cholesterol levels were less consistent(22,32). Again,
association may have been stronger if speciﬁcally analysing
intake of high-soluble ﬁbre grains. Cross-sectional studies are
inherently unable to capture the impact of long-term trends in
intake, and sample sizes were relatively small within both
studies. For example, while a 4·7 % lower LDL-cholesterol level,
as found in one study comparing highest consumers of cereal
ﬁbre with lowest consumers(32), may appear clinically relevant
to reduced CVD risk(42), it did not quite reach statistical signiﬁcance (P = 0·07).
It is thought that whole grains may contribute to weight loss
through the effect of ﬁbre on satiation and satiety(43), leading to
lower energy intake. In addition, the secretion of particular gut
hormones such as cholecystokinin may contribute to satiety or
alter glucose homoeostasis(44), and soluble ﬁbre may improve
insulin sensitivity by slowing the absorption of macronutrients,
indirectly affecting body weight(43). While the inverse association within the HPFS between whole grain, added bran and
cereal ﬁbre intake and weight gain over an 8-year period were
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statistically signiﬁcant, the weight change differences between
the highest and lowest intake were modest(21). Considering the
ﬁndings for whole grains and ﬁbre intake effect on weight
regulation in clinical trials tend to be inconsistent(45–47), further
research investigating this relationship is needed.
Within this review, whole grain intake tended to be associated with lower incidence of T2DM and the metabolic syndrome, but this association consistently disappeared after
adjustments for cereal ﬁbre intake. The one study that did not
perform adjustments for cereal ﬁbre intake found similar risk
reductions between whole grain and bran(19). High-soluble
ﬁbre foods have been found to reduce post-prandial glucose
and insulin response(48) and high-ﬁbre diets may improve
insulin sensitivity and lower insulin secretion(49). Interestingly,
two studies within the review found that insoluble ﬁbre but not
soluble ﬁbre was associated with lower risk of T2DM(26,27).
Insoluble ﬁbre may also slow the absorption of foods(50), but it
is also suggested that a quicker transit time, achieved with highinsoluble ﬁbre intake, allows less time for carbohydrates to be
absorbed in the upper jejunum, thus relieving insulin demand(51).
Both whole grain and cereal ﬁbre intake were associated with
signiﬁcantly lower HOMA-IR, a measure of insulin resistance, in
the Framingham cohort even after adjustment for relevant lifestyle and dietary factors. However, the whole grain association
disappeared after adjustment for cereal ﬁbre(28).
In addition to the ﬁbre content, micronutrients within whole
grains such as Mg may also play a role in insulin sensitivity and
reduced risk of T2DM. In a small study of elderly participants,
4·5 g of Mg daily for 4 weeks improved glucose and insulin
responses(52). Within our review, the importance of Mg intake
was inconclusive. Some studies found that Mg intake could not
explain the whole grain association(19,26), while another found
Mg was independently associated with reduced risk of T2DM,
even after adjustment for cereal ﬁbre(27). Importantly, this study
did not adjust for any other related dietary factors that may
confound these associations. Overall, the ﬁndings suggest that
the ﬁbre component of whole grains and bran may play the
major role in the inverse association with T2DM. Other nutrients
such as Mg may also contribute.
CRP was the only inﬂammatory marker regularly assessed.
Elevated CRP concentrations, a marker of inﬂammation, have
been found to independently predict CVD in the general
population(53) and people with T2DM(54), and the American
Heart Association has concluded that the risk of CVD is lower
when the CRP level is below 1 mg/l(55). Here, high whole grain,
bran and cereal ﬁbre intake were signiﬁcantly associated with
lower CRP concentrations in the same cohort of women with
T2DM(17). Within a healthy population, high whole grain and
bran intake tended to be associated with lower CRP concentrations; however, after adjustment for dietary and lifestyle
factors, the association completely disappeared for whole grain
and became non-signiﬁcant for bran(22). Hyperglycaemia may,
in part, inﬂuence production of pro-inﬂammatory cytokines(56,57), so whole grain and cereal ﬁbre intake may assist in
inhibiting inﬂammation through an effect on blood glucose
control.
The ﬁndings of this review suggest that ﬁbre may play a
signiﬁcant role in the cardio-protective association of whole
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grains. Whole grain, bran and cereal ﬁbre intake were associated with similarly lowered risks of most outcomes assessed,
and when tested, cereal ﬁbre often accounted considerably for
whole grain associations, particularly for T2DM. When bran was
separated from whole grains as in the initial analysis, intake of
bran, particularly added bran, had equal or stronger inverse
association with various CVD-related outcomes to that of whole
grains. As bran contains the majority of cereal ﬁbre within
grains, this may further support the notion that ﬁbre contributes
considerably to the protective associations of grains. Of course,
it is important to note that bran cannot be interpreted simply as
a direct measure of cereal ﬁbre, due to the abundance of
minerals, phytochemicals and phyto-oestrogens contained
within the aleurone layer(58). In the HPFS cohort, adjusting for
ﬁbre and micronutrient constituents attenuated the inverse
association between whole grains and CHD but did not have an
appreciable effect on the strong inverse association for added
bran(5). Further, Jacobs et al.(30) found that consumers of ﬁbre
from whole grain sources (which included bran) compared with
ﬁbre from reﬁned grain sources tended to have lower risk of allcause mortality but not speciﬁcally CVD mortality. We cannot
disregard the possibility that these bioactive compounds within
the bran aleurone layer, botanically linked to ﬁbre, may contribute to the inverse associations found(30).
Another important consideration in examining associations
between whole grains and CVD-related outcomes is the diet
and lifestyle of whole grain consumers, beyond whole grain
consumption. Whole grain intake may be associated with an
overall healthier lifestyle and better diet quality(59), and some of
these associated factors such as higher physical activity levels,
lower incidence of smoking and higher fruit and vegetable
intake may confound or contribute to any associations
attributed to whole grain intake. Within the initial analysis, all
seven of the good quality articles included careful adjustment
for multiple lifestyle and dietary factors in their multivariate
models. However, the fair quality article(17) observing associations with markers of inﬂammation included lifestyle factors
within the multivariate model, without inclusion of potentially
relevant dietary factors such as polyunsaturated fat intake(60).
Similarly, several of the articles included within the expanded
analysis failed to adjust for factors such as physical activity
status(26,31,32,34), alcohol intake(26) and other dietary factors(27).
In some cases, articles reporting on the same study cohorts
adjusted for considerably different factors within their
multivariate models. As causation cannot be determined from
observational studies, it is crucial that careful adjustment is
made for all potentially confounding factors. The inconsistency
among several articles within the review, particularly within the
expanded analysis, may limit the quality of the overall evidence.
Many of the articles within this review also went on to adjust
for constituents within the whole grain, including cereal ﬁbre. It
was interesting that associations found within the initial analysis
were less prone to attenuation after adjustment for cereal ﬁbre
than in the expanded analysis. Using an accepted deﬁnition of
whole grain (including all fractions in natural proportions), and
methodical calculation of whole grain, bran and cereal ﬁbre
intake, results are less likely to be confounded by imprecise
categorisation. We can therefore be more conﬁdent that the
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abundance of nutrients expected to be found within whole
grains and the separate bran component were accurately captured in estimated intake. Beyond the incorrect inclusion of
added bran, it is possible that the presence of non-whole grain
(and therefore potentially nutrient poor) grain intake incorrectly
captured as whole grain intake within the expanded analysis
diluted the overall quality of intake and therefore blunted the
contribution of any whole grain nutrients beyond cereal ﬁbre.
The noticeable difference in results between initial and
expanded analysis suggests that while it is evident that cereal
ﬁbre is an important component of whole grain and bran, we
cannot disregard contribution from nutrients beyond this.
The inconsistency in deﬁnitions and categorisation systems
used, and therefore limited amount of evidence based on the
correct deﬁnition of whole grains, is a considerable limitation of
this review. Only three major study cohorts (the NHS I and II
and the HPFS) were analysed using the correct deﬁnition of
whole grains. In addition, while the wide variety of CVD-related
outcomes assessed shed light on the various ways whole grain
intake may be protective, we were limited in our ability to draw
sound conclusions about any one risk factor or outcome, as
most outcomes were assessed in few studies, in diverse populations, or using different deﬁnitions of whole grain, making a
more in-depth study of results by way of a meta-analysis not
possible.

data and lack of agreement. These studies are needed before
ﬁndings can be translated into practical application. Most
importantly, there is a crucial need for future research to utilise
a consistent, methodical and quantiﬁed approach when calculating whole grain intake to ensure future evidence in this area
is consistent and accurate and reﬂects the current deﬁnition of
whole grain.
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Conclusion
Intake of whole grain, cereal ﬁbre and bran (total and added)
appeared to be similarly associated with lower risk of various
CVD-related risk factors and outcomes within this review,
suggesting that the ﬁbre component of whole grains, located
primarily within the bran fraction, may play an important role in
the cardio-protective associations observed with whole grain
intake. Notably, however, when the accepted deﬁnition and
precise categorisation of whole grain and bran intake were
used, association found were stronger and less prone to
attenuation after adjustment for cereal ﬁbre, potentially indicating a role of whole grain nutrients beyond ﬁbre.
The ﬁndings from this review are interesting in consideration
of the promotion of grain foods in public health initiatives and
dietetic practice. Potentially, an overly restricted focus on whole
grain cereal foods may deter consumption of high-ﬁbre nonwhole grain foods such as bran-based cereals. The similar lower
risks observed for added bran separate to whole grain across
both analyses raise the question of whether current initiatives
and health policies should include mention of whole grain and/
or bran foods. Indeed, this question may also be valuable for
the food industry, whereby the reformulation of cereal products
containing extrinsically sourced cereal ﬁbre or ﬁne bran may
overcome sensory barriers to whole grain foods – while still
providing cardio-protective beneﬁts. Future adequately powered studies, including intervention studies comparing the
effects of whole grain intake with ﬁbre-matched bran or addedcereal ﬁbre intake on CVD-related risk factors and outcomes,
are needed to establish the mechanisms behind the protective
effects of whole grains and their components as well as the
dose–response relationships, where there is currently paucity of

References
1. World Health Organization (2017) Cardiovascular diseases
fact sheet. http://www.who.int/mediacentre/factsheets/fs317/
en/ (accessed February 2018).
2. Pearson TA (2002) AHA Guidelines for Primary Prevention of
Cardiovascular Disease and Stroke: 2002 Update: Consensus
Panel Guide to Comprehensive Risk Reduction for Adult
Patients Without Coronary or Other Atherosclerotic Vascular
Diseases. Circulation 106, 388–391.
3. Yusuf S, Hawken S, Ounpuu S, et al. (2004) Effect of potentially modiﬁable risk factors associated with myocardial
infarction in 52 countries (the INTERHEART study): case–
control study. Lancet 364, 937–952.
4. He M, van Dam RM, Rimm E, et al. (2010) Whole-grain, cereal
ﬁber, bran, and germ intake and the risks of all-cause and
cardiovascular disease-speciﬁc mortality among women with
type 2 diabetes mellitus. Circulation 121, 2162–2168.
5. Jensen MK, Koh-Banerjee MF, Hu FB, et al. (2004) Intakes of
whole grains, bran, and germ and the risk of coronary heart
disease in men. Am J Clin Nutr 80, 1492–1499.
6. Theuwissen E & Mensink RP (2008) Water-soluble dietary ﬁbers
and cardiovascular disease. Physiol Behav 94, 285–292.
7. Fardet A (2010) New hypotheses for the health-protective
mechanisms of whole-grain cereals: what is beyond ﬁbre?
Nutr Res Rev 23, 65–134.
8. Cassidy A & Hooper L (2006) Phytoestrogens and cardiovascular disease. J Br Menopause Soc 12, 49–56.
9. Aune D, Keum N, Giovannucci E, et al. (2016) Whole grain
consumption and risk of cardiovascular disease, cancer, and all
cause and cause speciﬁc mortality: systematic review and dose–
response meta-analysis of prospective studies. BMJ 353, i2716.
10. Ye EQ, Chacko SA, Chou EL, et al. (2012) Greater whole-grain
intake is associated with lower risk of type 2 diabetes, cardiovascular disease, and weight gain. J Nutr 142, 1304–1313.

Downloaded from https://www.cambridge.org/core. University of Wollongong, on 25 Mar 2019 at 22:55:33, subject to the Cambridge Core terms of use, available at https://www.cambridge.org/core/terms. https://doi.org/10.1017/S000711451900031X

22

11. Jacobs DR Jr, Meyer KA, Kushi LH, et al. (1998) Whole-grain
intake may reduce the risk of ischemic heart disease death in
postmenopausal women: the Iowa Women’s Health Study.
Am J Clin Nutr 68, 248–257.
12. Ross AB, van der Kamp JW, King R, et al. (2017) Perspective: a
deﬁnition for whole-grain food products-recommendations
from the healthgrain forum. Adv Nutr 8, 525–531.
13. Liberati A, Altman DG, Tetzlaff J, et al. (2009) The PRISMA
statement for reporting systematic reviews and meta-analyses
of studies that evaluate healthcare interventions: explanation
and elaboration. PLoS Med 6, e1000100.
14. American Association of Cereal Chemists International (2017))
Standard deﬁnitions and resources: whole grain. http://www.
aaccnet.org/initiatives/deﬁnitions/Pages/WholeGrain.aspx
(accessed September 2017).
15. National Health and Medical Research Council (2000) How to
use the evidence: assessment and application of scientiﬁc
evidence. https://www.nhmrc.gov.au/guidelines-publications/
cp69 (accessed September 2017).
16. National Institute of Health (2014) Quality assessment tool for
observational cohort and cross-sectional studies. https://www.
nhlbi.nih.gov/health-pro/guidelines/in-develop/cardiovascularrisk-reduction/tools/cohort (accessed September 2017).
17. Qi L, van Dam RM, Liu S, et al. (2006) Whole-grain, bran, and
cereal ﬁber intakes and markers of systemic inﬂammation in
diabetic women. Diabetes Care 29, 207–211.
18. Wu H, Flint AJ, Qi Q, et al. (2015) Association between dietary
whole grain intake and risk of mortality: two large prospective
studies in US men and women. JAMA Intern Med 175,
373–384.
19. de Munter JSL, Hu FB, Spiegelman D, et al. (2007) Whole
grain, bran, and germ intake and risk of type 2 diabetes: a
prospective cohort study and systematic review. PloS Med 4,
e261.
20. Flint AJ, Hu FB, Glynn RJ, et al. (2009) Whole grains and
incident hypertension in men. Am J Clin Nutr 90, 493–498.
21. Koh-Banerjee MF, Franz M, Sampson L, et al. (2004) Changes
in whole-grain, bran, and cereal ﬁber consumption in
relation to 8-y weight gain among men. Am J Clin Nutr 80,
1237–1245.
22. Jensen MK, Koh-Banerjee MF, Sampson L, et al. (2006) Whole
grains, bran, and germ in relation to homocysteine and markers of glycemic control, lipids, and inﬂammation. Am J Clin
Nutr 83, 275–283.
23. Liu S, Stampfer MJ, Hu FB, et al. (1999) Whole-grain consumption and risk of coronary heart disease: results from the
Nurses’ Health Study. Am J Clin Nutr 70, 412–308.
24. Juan J, Liu G, Willett WC, et al. (2017) Whole grain
consumption and risk of ischemic stroke: results from 2
prospective cohort studies. Stroke 48, 3203–3209.
25. Fung TT, Hu FB, Pereira MA, et al. (2002) Whole-grain intake
and the risk of type 2 diabetes: a prospective study in men.
Am J Clin Nutr 76, 535–540.
26. Montonen J, Knekt P, Jarvinen R, et al. (2003) Whole-grain
and ﬁber intake and the incidence of type 2 diabetes. Am J
Clin Nutr 77, 622–629.
27. Meyer KA, Kushi LH, Jacobs DR, et al. (2000) Carbohydrates,
dietary ﬁber, and incident type 2 diabetes in older women. Am
J Clin Nutr 71, 921–930.
28. McKeown NM, Meigs JB, Liu S, et al. (2004) Carbohydrate
nutrition, insulin resistance, and the prevalence of the metabolic syndrome in the Framingham Offspring Cohort. Diabetes
Care 27, 538–546.
29. Huang T, Xu M, Lee A, et al. (2015) Consumption of whole
grains and cereal ﬁber and total and cause-speciﬁc mortality:
prospective analysis of 367,442 individuals. BMC Med 13, 59.

23

30. Jacobs DR, Pereira MA, Meyer KA, et al. (2000) Fiber from
whole grains, but not reﬁned grains, is inversely associated
with all-cause mortality in older women: the Iowa Women’s
Health Study. J Am Coll Nutr 19, Suppl. 3, 326S–330S.
31. Erkkila AT, Herrington DM, Mozaffarian D, et al. (2005) Cereal
ﬁber and whole-grain intake are associated with reduced
progression of coronary-artery atherosclerosis in postmenopausal women with coronary artery disease. Am Heart J
150, 94–101.
32. Newby PK, Maras J, Bakun P, et al. (2007) Intake of whole
grains, reﬁned grains, and cereal ﬁber measured with 7-d diet
records and associations with risk factors for chronic disease.
Am J Clin Nutr 86, 1745–1753.
33. McKeown NM, Yoshida M, Shea MK, et al. (2009) Whole-grain
intake and cereal ﬁber are associated with lower abdominal
adiposity in older adults. J Nutr 139, 1950–1955.
34. van de Vijver LP, van den Bosch LM, van den Brandt PA, et al.
(2009) Whole-grain consumption, dietary ﬁbre intake and
body mass index in the Netherlands cohort study. Eur J Clin
Nutr 63, 31–38.
35. Jenkins DJ, Kendall CW, Axelsen M, et al. (2000) Viscous and
non-viscous ﬁbres, non-absorbable and low glycaemic index
carbohydrates, blood lipids and coronary heart disease. Curr
Opin Lipidol 11, 49–56.
36. Juntunen KS, Laaksonen DE, Poutanen KS, et al. (2003) Highﬁber rye bread and insulin secretion and sensitivity in healthy
postmenopausal women. Am J Clin Nutr 77, 385–391.
37. Appel LJ, Moore TJ, Obarzanek E, et al. (1997) A clinical trial
of the effects of dietary patterns on blood pressure. N Engl J
Med 336, 1117–1124.
38. King DE, Egan BM & Geesey ME (2003) Relation of dietary fat
and ﬁber to elevation of C-reactive protein. Am J Cardiol 92,
1335–1339.
39. Ballantyne CM (1998) Clinical trial endpoints: angiograms,
events, and plaque instability. Am J Cardiol 82, Suppl. 1,
5M–11M.
40. Anderson JW, Gilinsky NH, Deakins DA, et al. (1991) Lipid
responses of hypercholesterolemic men to oat-bran and
wheat-bran intake. Am J Clin Nutr 54, 678–683.
41. Davy BM, Davy KP, Ho RC, et al. (2002) High-ﬁber oat cereal
compared with wheat cereal consumption favorably alters
LDL-cholesterol subclass and particle numbers in middle-aged
and older men. Am J Clin Nutr 76, 351–358.
42. National Cholesterol Education Program (NCEP) Expert Panel
on Detection, Evaluation, and Treatment of High Blood
Cholesterol in Adults (Adult Treatment Panel III) (2002) Third
Report of the National Cholesterol Education Program (NCEP)
Expert Panel on Detection, Evaluation, and Treatment of High
Blood Cholesterol in Adults (Adult Treatment Panel III)
ﬁnal report. Circulation 106, 3143–3421.
43. Koh-Banerjee P & Rimm EB (2003) Whole grain consumption
and weight gain: a review of the epidemiological evidence,
potential mechanisms and opportunities for future research.
Proc Nutr Soc 62, 25–29.
44. Pereira MA & Ludwig DS (2001) Dietary ﬁber and bodyweight regulation. Observations and mechanisms. Pediatr
Clin North Am 48, 969–980.
45. Brownlee IA, Moore C, Chatﬁeld M, et al. (2010) Markers of
cardiovascular risk are not changed by increased whole-grain
intake: the WHOLEheart study, a randomised, controlled
dietary intervention. Br J Nutr 104, Suppl. 1, 125S–134S.
46. Rave K, Roggen K, Dellweg S, et al. (2007) Improvement of
insulin resistance after diet with a whole-grain based dietary
product: results of a randomized, controlled cross-over study
in obese subjects with elevated fasting blood glucose. Br J
Nutr 98, 929–936.

Downloaded from https://www.cambridge.org/core. University of Wollongong, on 25 Mar 2019 at 22:55:33, subject to the Cambridge Core terms of use, available at https://www.cambridge.org/core/terms. https://doi.org/10.1017/S000711451900031X

Whole grains and CVD

E. M. Barrett et al.

47. Melanson KJ, Angelopoulos TJ, Nguyen VT, et al. (2006)
Consumption of whole-grain cereals during weight loss effects
on dietary quality, dietary ﬁber, magnesium, vitamin B-6, and
obesity. J Am Diet Assoc 106, 1380–1388.
48. Jenkins D, Wolever T, Leeds AR, et al. (1978) Dietary ﬁbres,
ﬁbre analogues, and glucose tolerance: importance of viscosity. Br Med J 1, 1392–1394.
49. Weickert MO, Mohlig M, Schöﬂ C, et al. (2006) Cereal ﬁber
improves whole-body insulin sensitivity in overweight and
obese women. Diabetes Care 29, 775–780.
50. Anderson JW (1986) Fiber and health: an overview. Am J
Gastroenterol 81, 892–897.
51. Cummings JH & Englyst HN (1987) Fermentation in the
human large intestine and the available substrates. Am J Clin
Nutr 45, 1243–1255.
52. Paolisso G, Sgambato S, Gambardella A, et al. (1992) Daily
magnesium supplements improve glucose handling in elderly
subjects. Am J Clin Nutr 55, 1161–1167.
53. Ridker PM, Buring JE, Cook NR, et al. (2003) C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events: an 8-year follow-up of 14,719 initially healthy
American women. Circulation 107, 391–397.
54. Schulze MB, Rimm EB, Li T, et al. (2004) C-reactive protein
and incident cardiovascular events among men with diabetes.
Diabetes Care 27, 889–894.

55. Pearson TA, Mensah GA, Alexander RW, et al. (2003) Markers
of inﬂammation and cardiovascular disease: application to
clinical and public health practice: a statement for healthcare
professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation 107,
499–511.
56. Gonzalez F, Minium J, Rote NS, et al. (2005) Hyperglycemia
alters TNF-alpha release from mononuclear cells in women
with polycystic ovary syndrome. J Clin Endocrinol Metab 90,
5336–5342.
57. Devaraj S, Venugopal SK, Singh U, et al. (2005) Hyperglycemia induces monocytic release of interleukin-6 via induction
of protein kinase c-alpha and -beta. Diabetes 54, 85–91.
58. Lillioja S, Neal AL, Tapsell L, et al. (2013) Whole grains, type
2 diabetes, coronary heart disease, and hypertension: links to
the aleurone preferred over indigestible ﬁber. Biofactors 39,
242–258.
59. Kyrø C, Skeie G, Dragsted L, et al. (2011) Intake of whole
grains in Scandinavia is associated with healthy lifestyle,
socio-economic and dietary factors. Public Health Nutr 14,
1787–1795.
60. Kris-Etherton PM, Harris WS & Appel LJ (2003) Omega-3 fatty
acids and cardiovascular disease: new recommendations from
the American Heart Association. Arterioscler Thromb Vasc
Biol 23, 151–152.

Downloaded from https://www.cambridge.org/core. University of Wollongong, on 25 Mar 2019 at 22:55:33, subject to the Cambridge Core terms of use, available at https://www.cambridge.org/core/terms. https://doi.org/10.1017/S000711451900031X

24

